Cardiovascular

In vitro studies suggest a KCNQ1 agonist could help treat long QT syndrome (LQTS) caused by KCNQ1 mutations. In Xenopus oocytes expressing eight LQTS-associated KCNQ1 mutations, a previously reported ...